Edition:
United States

Insider Trading: Bio Rad Laboratories Inc (BIO)

BIO on New York Consolidated

173.50USD
30 Nov 2016
Change (% chg)

-- (--)
Prev Close
$173.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
140,816
52-wk High
$174.77
52-wk Low
$122.03

All Insider Trades
Trading Date Name Title Type Shares Traded Price
8 Nov 2016

Stark James R

Officer Sell 1,299 $171.42
6 Nov 2016

Crowley (Michael)

Officer Sell 88 $165.62
6 Nov 2016

Hall (Shannon)

Officer Sell 84 $165.62
6 Nov 2016

Hertia John

Officer Sell 227 $165.62
6 Nov 2016

Magni (Giovanni)

Officer Sell 91 $165.62
6 Nov 2016

Stark James R

Officer Sell 76 $165.62
3 Nov 2016

Hutton Ronald W

Officer and Treasurer Buy 140 $0.00
3 Nov 2016

Goetz (John P)

Chief Operating Officer Sell 126 $164.74
3 Nov 2016

Hertia John

Officer Buy 600 $0.00
3 Nov 2016

Crowley (Michael)

Officer Buy 231 $0.00
3 Nov 2016

Stark James R

Officer Buy 200 $0.00
3 Nov 2016

Hutton Ronald W

Officer and Treasurer Sell 53 $164.74
3 Nov 2016

Tsingos (Christine A)

Chief Financial Officer Buy 200 $0.00
3 Nov 2016

Schwartz (Norman D)

Chief Executive Officer Buy 2,400 $0.00
3 Nov 2016

Hall (Shannon)

Officer Buy 220 $0.00
3 Nov 2016

Schwartz (Norman D)

Chief Executive Officer Sell 1,253 $164.74
3 Nov 2016

Goetz (John P)

Chief Operating Officer Buy 240 $0.00
3 Nov 2016

Tsingos (Christine A)

Chief Financial Officer Sell 76 $164.74
3 Nov 2016

Magni (Giovanni)

Officer Buy 240 $0.00
12 Sep 2016

Magni (Giovanni)

Officer Sell 92 $158.07
12 Sep 2016

Hertia John

Officer Sell 228 $158.08
12 Sep 2016

Crowley (Michael)

Officer Sell 127 $158.09
12 Sep 2016

Stark James R

Officer Sell 76 $158.09
12 Sep 2016

Hall (Shannon)

Officer Sell 92 $158.08
11 Sep 2016

Tsingos (Christine A)

Chief Financial Officer Buy 200 $0.00

Institutional Holders

% Shares Owned: 78.98%
# of Holders: 313
Total Shares Held: 19,192,389
3 Mo. Net Change: -49,010
# New Positions: 31
# Closed Positions: 29
# Increased Positions: 129
# Reduced Positions: 129
# Net Buyers: 0

Officers & Directors

Name Age Since Current Position

Norman Schwartz

70 2012 Chairman of the Board, President, Chief Executive Officer

Christine Tsingos

57 2012 Chief Financial Officer, Executive Vice President

John Goetz

66 2014 Chief Operating Officer, Executive Vice President

Michael Crowley

54 2014 Executive Vice President, Global Commercial Operations

Shannon Hall

46 2014 Executive Vice President, President, Life Science Group

John Hertia

60 2014 Executive Vice President, President, Clinical Diagnostics Group

Giovanni Magni

59 2014 Executive Vice President, Chief Strategy Officer

Ronald Hutton

58 2012 Vice President, Treasurer

Alice Schwartz

89 1967 Director

Louis Drapeau

72 2007 Independent Director

Robert Malchione

58 2014 Independent Director

Joel McComb

51 2014 Independent Director

Deborah Neff

63 2011 Independent Director